India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
Tetanus vaccine should be given to the child under what circumstances? Tetanus is a serious and deadly disease. whose vaccination is considered mandatory for the safety of children. This disease is usually transmitted by tetanus bacteria found in soil, dust or dirty objects, which enter the body through injuries. Tetanus bacteria can survive in the body for years. The titanospasmin produced by it seems to have a bad effect on our nervous system, brain and muscles. Boiling these germs in water for 20 minutes does not kill them. Germs become active after entering the body through a wound. Symptoms of tetanus Symptoms of tetanus appear after a week or two after the tetanus bacteria enter the body. There is fever, diarrhea, headache. Problems such as jaw muscle stiffness and difficulty in opening and closing the mouth, difficulty in eating and drinking, stomach ache, muscle contraction in the back of the body are seen. Symptoms of tetanus include increased pain in the muscles, rapid b...